SANOFI INDIA
|
The Current P/E Ratio of SANOFI INDIA is 23.07.
| Share Price | ₹3,106.9 | May 29,2026 |
| Market Cap | ₹7,145.8 Cr | |
| Earnings-TTM | ₹309.8 Cr | TTM-Standalone Results |
| Price/Earnings | 23.07x | Calculated as Market Cap/Earnings |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PE (Price/Earnings) ratio of SANOFI INDIA
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹7,145.8 Cr] as on May 29,2026
(/) Earnings [ ₹309.8 Cr] based on TTM-Standalone Results
(=) P/E Ratio [ 23.07x ]
Thus, for SANOFI INDIA , the investors are currently willing to pay 23.07 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of SANOFI INDIA !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of SANOFI INDIA over the last five years.
Historical PE (Price/Earnings) ratio chart of SANOFI INDIA
PE Ratio Performance Analysis for SANOFI INDIA
- SANOFI INDIA 's p/e ratio for fiscal years ending Dec2025 to Dec2021 averaged 33.10x.
- SANOFI INDIA 's operated at median p/e ratio of 28.81x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, SANOFI INDIA 's p/e ratio peaked in Dec2023 at 50.89x.
- SANOFI INDIA 's p/e ratio hit its five-year low in Dec2021 of 19.22x.
How does SANOFI INDIA 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
|---|---|---|---|
| SANOFI INDIA | 309.80 | 23.07 | 7,145.8 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 11,564.50 | 37.36 | 432,096.0 |
| DIVIS LABORATORIES LTD | 2,568.00 | 68.85 | 176,807.0 |
| TORRENT PHARMACEUTICALS LTD | 2,138.00 | 69.56 | 148,718.0 |
| CIPLA LTD | 3,869.79 | 29.19 | 112,971.0 |
| DR REDDYS LABORATORIES LTD | 4,144.20 | 26.24 | 108,752.0 |
| MANKIND PHARMA LTD | 1,926.41 | 50.97 | 98,179.5 |
| LUPIN LTD | 5,355.47 | 19.40 | 103,900.0 |
| ZYDUS LIFESCIENCES LTD | 5,026.40 | 21.57 | 108,442.0 |
| AUROBINDO PHARMA LTD | 3,501.45 | 23.51 | 82,330.8 |
| LAURUS LABS LTD | 889.85 | 82.61 | 73,506.9 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs SANOFI INDIA 's P/E Ratio
| Top 10 Industry Peers | PE Ratio |
|---|---|
| Min industry PE | 19.40x |
| Max industry PE | 82.61x |
| Median industry PE | 29.19x |
| Average industry PE | 41.12x |
You may also like the below Video Courses